Results

The latest key achievements of the consortium work:

• Generic Clinical Qualification Process for Translational Safety Biomarkers

• DIKI BM qualification strategy: A consortium for the regulatory qualification of human kidney biomarkers to monitor drug-induced kidney injury -SAFE-T_ERAEDTA_FINAL.pdf

• DILI BM qualification strategy: DILI article in Regulatory Toxicology and Pharmacology -DILI.pdf ; DILI conference March 24 2011QUALIFICATION_OF_NEW_TRANSLATIONAL_SAFETY_BIOMARKERS.pdf 

• DIVI BM qualification strategy: -DIVI_BM_qualification_strategy.pdf  -DIVI_update_for_IMI.pdf